LogicMark Launches 2 Products, Care Village Platform and Web App

FLG partner Mark Archer, CFO at LogicMark (Nasdaq: LGMK) was delighted to help ring the market closing bell from Nasdaq’s headquarters in NYC as the company celebrated the December 2023 launch of its two new products, a SaaS medical mobile alert device (the Freedom Alert Plus) for the B-to-C market of seniors and…Read More

Read More
Lassen Therapeutics Closes $85M Oversubscribed Series B Financing

San Diego, CA, December 19, 2023 – Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics, today announced the closing of an oversubscribed Series B financing which raised $85 million. Frazier Life Sciences co-led the financing along with new investor Longitude Capital. The syndicate also included new investors BVF…Read More

Read More
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing

SAN MATEO, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced it has raised over $31 million in a Series F financing to accelerate the commercial adoption of a neurovascular intervention…Read More

Read More
MidCap Financial Closes $23MM Senior Revolving Credit Facility for Wine.com

ABL Advisor (Bryn Mawr, PA) November 9, 2023 – MidCap Financial (managed by Apollo Capital Management, L.P., a subsidiary of Apollo Global Management, Inc.) has provided a $23 million senior revolving credit facility to Wine.com with the option to increase to $30M. The MidCap credit facility is part of a successful refinancing of…Read More

Read More
Soleno Therapeutics Closes $129 Million Public Offering

REDWOOD CITY, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the closing of the underwritten public offering of 3,450,000 shares of its common stock at a public offering…Read More

Read More